Product image of Lenzetto (Estradiol Hemihydrate) supplied by GNH India

Lenzetto

Active Ingredient:
Estradiol Hemihydrate
Origin:
EU

Lenzetto (Estradiol Hemihydrate)

Estradiol, the active ingredient in Lenzetto, is a estrogen presented as a 0.025 mg/24 h transdermal patch for transdermal use. It treats moderate to severe vasomotor symptoms of menopause and helps prevent osteoporosis in postmenopausal women. Lenzetto provides a steady systemic estrogen level through skin absorption, supporting bone health and alleviating hot flashes.

GNH India supplies Lenzetto as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lenzetto, an estrogen transdermal system, is used to manage menopausal vasomotor symptoms and to protect bone health.

  • Menopausal vasomotor symptoms: reduces frequency and severity of hot flashes and night sweats.
  • Osteoporosis prevention: helps maintain bone mineral density in postmenopausal women.
  • Estrogen deficiency due to ovarian failure: restores estrogen levels to alleviate related symptoms.

How It Works

  • Estradiol in Lenzetto binds to intracellular estrogen receptors ERα and ERβ, forming a hormone‑receptor complex that interacts with estrogen response elements on DNA. This modulates transcription of target genes, leading to restoration of estrogenic activity in tissues such as the hypothalamus, bone, and cardiovascular system, thereby alleviating menopausal symptoms and supporting bone metabolism.

Side Effects

Lenzetto may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Skin irritation at the patch site: redness, itching, or rash.
  • Nausea: mild gastrointestinal discomfort.
  • Breast tenderness: swelling or sensitivity.
  • Headache: occasional mild headache.

Serious or Rare Side Effects

  • Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
  • Stroke or myocardial infarction: increased risk of cardiovascular events.
  • Endometrial hyperplasia or carcinoma: abnormal uterine bleeding and potential malignancy.

Precautions & Warnings

Before prescribing Lenzetto, clinicians should consider several safety measures.

  • Assess cardiovascular risk: evaluate history of thromboembolic disease before initiating.
  • Screen for estrogen‑dependent neoplasia: avoid in known breast, uterine, or ovarian cancer.
  • Monitor bone health: consider baseline bone mineral density assessment.
  • Counsel on smoking: advise cessation as smoking increases clot risk.
  • Review liver function: adjust use in severe hepatic impairment.
  • Store at room temperature below 25°C: keep in original pouch, protect from moisture and light.

Avoid Interactions

Estradiol can interact with several drug classes, requiring caution.

Major Interactions (Avoid)

  • Combined hormonal contraceptives: increase risk of thromboembolism.
  • Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, requiring monitoring.
  • CYP3A4 inducers (rifampin, carbamazepine): reduce estradiol levels, decreasing efficacy.

Moderate Interactions (Monitor Closely)

  • SSRIs used for hot flashes: may diminish vasomotor symptom relief.
  • Antihypertensive agents: estrogen may affect blood pressure control.
  • Thyroid hormone replacement: estradiol may alter thyroid‑binding globulin levels.

Frequently Asked Questions

Lenzetto is a transdermal estradiol patch indicated for relief of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats, and for the prevention of osteoporosis in postmenopausal women.

Estradiol in Lenzetto binds to estrogen receptors ERα and ERβ in target cells, forming a complex that regulates gene transcription. This restores estrogenic activity in tissues involved in temperature regulation, bone remodeling, and cardiovascular function.

The prescribed dose of Lenzetto is determined by the treating physician based on individual needs. The patch is designed to deliver a steady 0.025 mg of estradiol per 24 hours, but exact dosing schedules are set by the prescriber.

Lenzetto is not indicated for use in pregnancy or while breastfeeding. Safety data are insufficient, and estrogen therapy can pose risks to the fetus and infant; therefore, it should be avoided in these situations.

To order Lenzetto, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lenzetto delivers estradiol through the skin, providing more consistent plasma levels and avoiding first‑pass hepatic metabolism, which can reduce gastrointestinal side effects seen with oral tablets. However, the patch may cause local skin irritation, while oral forms may have higher hepatic effects.

Lenzetto should be stored at room temperature below 25 °C, in its original pouch, protected from moisture and direct light. Keep the patch in a dry place and avoid exposing it to excessive heat or humidity.

Lenzetto is applied to clean, dry, intact skin on the lower abdomen or buttock. The patch is pressed firmly for several seconds, then left in place for 24 hours before being removed and replaced with a new patch at a different site.

Serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), stroke or myocardial infarction, and estrogen‑dependent cancers such as endometrial hyperplasia or carcinoma. Patients should be monitored for signs of clotting or abnormal bleeding.

Lenzetto is contraindicated in women with a history of estrogen‑dependent cancers (breast, uterine, ovarian), active or past thromboembolic disease, severe liver disease, or known pregnancy. It should also be used with caution in smokers and those with uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Estradiol Hemihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT